Age (median) | 59.0 | (Range 25-84) |
---|---|---|
WHO performance status | Â | (%) |
  0 | 37 | (28.2) |
  1 | 66 | (50.4) |
  2 | 21 | (16.0) |
  3 | 6 | (4.6) |
FIGO-stage | Â | Â |
  IA | 39 | (29.8) |
  IB | 6 | (4.6) |
  IC | 66 | (50.4) |
  II | 20 | (15.3) |
Histopathology | Â | Â |
  Serous | 51 | (38.9) |
  Mucinous | 20 | (15.3) |
  Endometrioid | 42 | (32.1) |
  Clear cell* | 16 | (12.2) |
  Anaplastic | 2 | (1.5) |
FIGO-grade | Â | Â |
  Grade 1 | 31 | (23.7) |
  Grade 2 | 45 | (34.4) |
  Grade 3* | 55 | (41.9) |